↓ Skip to main content

Cochrane Database of Systematic Reviews

Tumor necrosis factor‐alpha antibody for maintenance of remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, January 2008
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
234 Dimensions

Readers on

mendeley
225 Mendeley
Title
Tumor necrosis factor‐alpha antibody for maintenance of remission in Crohn's disease
Published in
Cochrane database of systematic reviews, January 2008
DOI 10.1002/14651858.cd006893
Pubmed ID
Authors

Brian W Behm, Stephen J Bickston

Abstract

Crohn's disease may be refractory to conventional treatments including corticosteroids and immunosuppressives. Recent studies suggest TNF-alpha blocking agents may be effective in maintaining remission in Crohn's disease.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 225 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Chile 1 <1%
Brazil 1 <1%
India 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Mexico 1 <1%
United States 1 <1%
Unknown 217 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 34 15%
Student > Master 30 13%
Student > Ph. D. Student 20 9%
Student > Bachelor 19 8%
Other 17 8%
Other 45 20%
Unknown 60 27%
Readers by discipline Count As %
Medicine and Dentistry 98 44%
Agricultural and Biological Sciences 12 5%
Nursing and Health Professions 10 4%
Biochemistry, Genetics and Molecular Biology 6 3%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Other 20 9%
Unknown 73 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2019.
All research outputs
#8,296,727
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#8,927
of 11,499 outputs
Outputs of similar age
#44,692
of 168,704 outputs
Outputs of similar age from Cochrane database of systematic reviews
#56
of 80 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,704 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.